U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385366) titled 'Developing & Evaluating Models for Early Predicting Obstetrical Diseases in Pregnant Women... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385379) titled 'Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tri... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385392) titled 'Continuous Wearable Monitor for the Detection and Release of Freezing of Gait' on April 22... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385418) titled 'Fluorouracil Treatment Via Colon for Colorectal Cancer' on April 17. Brief Summary: Fluor... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385431) titled 'Obeservational Cohort for Evaluating Future Cardiovascular Disease With High Metabolic Ris... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385444) titled 'IVF Failure and Pregnancy Loss on Couples' Psychological Stress' on April 17. Brief Summa... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385457) titled 'The Effects of Mindhelper on Young People's Well-being, Psychological Functioning, and Int... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385470) titled 'Treatment of Cantonese Speakers With Childhood Apraxia of Speech' on April 22. Brief Summ... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385483) titled 'Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (M... Read More
U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385496) titled 'Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With mTOR Genetic C... Read More